600079 ST人福医药
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额1,002,4622,518,7242,164,2651,967,2502,441,071
投资活动产生之现金流量净额(146,697)(390,372)(742,025)(1,224,718)1,226,790
筹资活动产生之现金流量净额92,986(1,801,100)(1,497,997)(2,105,567)(4,244,942)
汇率变动对现金及现金等价物的影响(42,047)(685)(23,867)16,29948,452
现金及现金等价物净增加/(减少)906,705326,567(99,624)(1,346,737)(528,629)
期初现金及现金等价物余额3,217,3872,890,8202,990,4454,337,1814,865,811
期末现金及现金等价物余额4,124,0923,217,3872,890,8202,990,4454,337,181